Harmony Biosciences Holdings, Inc. (HRMY) delivered earnings and revenue surprises of 104% and 2.80%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Harmony Biosciences Holdings, Inc. (HRMY) Beats Q1 Earnings Estimates